These Pharma Stock Calls Could Double

Wall Street's "fear gauge" closed at its lowest point since late July

 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

MARKET RECAP     9/11/2019
Our #1 Micro-Cap Stock to Own Today On September 10, 2018, a tiny Cambridge biotech firm won a patent on a new kind of treatment that can "Cut & Paste" any disease from your body. It's like this tiny biotech invented the iPhone while Big Pharma is still selling flip phones. That's why we believe anyone who gets in today could turn every $1,000 into $1.54 million (or more)!
Six Straight Wins For Dow; Nasdaq Snaps Skid By Patrick Martin Share On The Dow cruised to a sixth straight win today, its longest winning streak since early June. Thanks to outsized gains from Apple (AAPL) and the latest trade tailwinds, the blue-chip index spent nearly the entire day in the black, and closed above the 27,000 level for the first time since July 30. The S&P 500 and Nasdaq also earned wins, with the latter snapping a three-day losing streak thanks to a resurgent tech sector. Elsewhere, Wall Street's "fear gauge" -- the VIX -- closed at its lowest point since July 30.  Continue reading for more on today's market, including: Call buyers could hit it big with these 2 pharma stocks. GameStop stock ended its recent winning streak after an earnings flop. iQiyi calls were hot during today's pop. Plus, 2 stocks that soared after earnings; puts pop on Broadcom; and Micron gets upgraded. >> Continue reading...
LATEST HEADLINES
>> IQ Call Traders Ignore Chart Resistance A prominent IQ trendline could spell trouble for this rally >> Pharma Stock Calls Could Double Fast Both names are trading near historical support at their 140-day trendlines >> 2 Stocks Soar on Earnings Beats Francesca's and Lovesac are in rally mode after their latest quarterly reports >> Dow Eyes Another Win as Tech Gains This would be a 6th straight win for the Dow >> Broadcom Puts Pop Ahead of Earnings Broadcom is set to report earnings after the close tomorrow Sponsored Our #1 Micro-Cap Stock to Own Today On September 10, 2018, a tiny Cambridge biotech firm won a patent on a new kind of treatment that can "Cut & Paste" any disease from your body. It's like this tiny biotech invented the iPhone while Big Pharma is still selling flip phones. That's why we believe anyone who gets in today could turn every $1,000 into $1.54 million (or more)!
To ensure delivery of Schaeffer's Market Recap, add us to your contacts! For more information, please visit this link for further instructions. This email was sent to phanhoa1821960.trader@blogger.com because you are a registered subscriber to Schaeffer's Market Recap or have signed up to receive emails from www.schaeffersresearch.com. Don't want to receive Schaeffer's Market Recap? You can unsubscribe here. For more information about our privacy practices, please review our Privacy Policy or our Terms & Conditions. Have a question, comment or concern? We’ll respond quickest if you call (800) 448-2080, email, or write to:
		SCHAEFFER'S MARKET RECAP enews@schaeffer.com 5151 Pfeiffer Rd. Suite 250 Cincinnati, OH, 45242 USA 800-448-2080 www.schaeffersresearch.com